GLATIRAJECT Trademark

Trademark Overview

On Friday, September 25, 2015, a trademark application was filed for GLATIRAJECT with the United States Patent and Trademark Office. The USPTO has given the GLATIRAJECT trademark a serial number of 86769205. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 16, 2018. This trademark is owned by Novartis AG. The GLATIRAJECT trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceuticals
glatiraject

General Information

Serial Number86769205
Word MarkGLATIRAJECT
Filing DateFriday, September 25, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 16, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2016

Trademark Statements

Goods and ServicesInjection device for pharmaceuticals
Translation of Words in MarkThe wording "GLATIRAJECT" has no meaning in a foreign language.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, October 1, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, April 16, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 16, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2017EXTENSION 3 GRANTED
Thursday, September 14, 2017EXTENSION 3 FILED
Thursday, September 14, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2017EXTENSION 2 GRANTED
Thursday, March 9, 2017EXTENSION 2 FILED
Thursday, March 9, 2017TEAS EXTENSION RECEIVED
Wednesday, September 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2016EXTENSION 1 GRANTED
Monday, September 12, 2016EXTENSION 1 FILED
Monday, September 12, 2016TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 4, 2015ASSIGNED TO EXAMINER
Thursday, October 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 29, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

glatiraject pharmaceuticals device injection